Fosamax ì/SPAN> Jaw lawsuit Information
Fosamax à(generic name - Alendronate) is a type of drug known as bisphosphonates. Recently a link
has been found between bisphosphonates and a serious bone disease called
osteonecrosis of the jaw (ONJ). This important discovery clearly
shows that Fosamax àside effects may include
osteonecrosis of the jaw.
The discovery, published in the Journal of Oral and
Maxillofacial Surgeons, prompted both the US, Food and Drug Administration (FDA) and Novartis, the manufacturer of bisphosphonates used in cancer
chemotherapy, to issue a warning to health care professionals on September 24,
2004. The warning letter contained information about bisphosphonates
and the risks of osteonecrosis in the jaw.
Bisphosphonates are commonly used in tablet form such
as Fosamax ì/SPAN> (Alendronate Sodium) to prevent and treat osteoporosis in
post-menopausal women. Stronger forms of bisphosphonates are commonly used in
the management of advanced cancers that have metastasized to the bone, where
the disease often causes bone pain and possibly even fractures. Several cancers
can involve or metastasize to the bone, including lung cancer, breast cancer,
prostate cancer, multiple myeloma, and others. When bisphosphonates are given
in cancer chemotherapy, the drugs are given intravenously, and usually for
longer periods of time.
If you have been injured by Fosamax àside
effects you may be entitled to compensation. For more information about your
legal rights contact the offices of
Powell Law Firm, L.C.
